|
End-of-day quote
Ghana S.E.
|
||
| - GHS | - |
|
| Market Cap | 5.2M 61.07M 4.64M 4.32M 3.93M 7.41M 503M 7.45M 51.96M 20.36M 256M 19.51M 19.09M 823M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 123M 9.33M 8.68M 7.89M 14.9M 1.01B 14.97M 104M 40.93M 515M 39.23M 38.37M 1.65B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 915K | |
| +0.52% | +2.92% | +37.51% | +105.72% | 1,043B | |
| +1.72% | +1.69% | +36.25% | +64.21% | 618B | |
| +1.43% | +5.25% | +19.91% | +85.51% | 481B | |
| +2.63% | +1.40% | +67.22% | +40.02% | 351B | |
| +1.45% | +3.50% | +21.87% | +42.64% | 338B | |
| +1.17% | +2.37% | +11.71% | +35.14% | 269B | |
| +0.89% | +1.08% | -7.28% | +10.52% | 244B | |
| +2.23% | +3.19% | +40.77% | +53.16% | 220B | |
| +2.61% | +4.16% | +29.14% | +100.85% | 182B | |
| Average | +1.75% | +0.28% | +28.57% | +59.75% | 374.67B | |
| Weighted average by Cap. | +1.47% | +0.60% | +31.43% | +69.84% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 105M 7.94M 7.39M 6.72M 12.69M 861M 12.74M 88.92M 34.84M 439M 33.39M 32.66M 1.41B | 9.91M 116M 8.85M 8.23M 7.49M 14.14M 959M 14.2M 99.09M 38.82M 489M 37.21M 36.4M 1.57B |
| Net income | 665K 7.82M 594K 553K 503K 949K 64.36M 953K 6.65M 2.61M 32.81M 2.5M 2.44M 105M | 762K 8.95M 680K 633K 575K 1.09M 73.7M 1.09M 7.61M 2.98M 37.58M 2.86M 2.8M 121M |
| Net Debt | 4.15M 48.74M 3.7M 3.45M 3.13M 5.92M 401M 5.94M 41.47M 16.25M 205M 15.57M 15.23M 657M | 5.25M 61.7M 4.69M 4.36M 3.97M 7.49M 508M 7.52M 52.49M 20.57M 259M 19.71M 19.28M 831M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
